vs
BED BATH & BEYOND, INC.（BBBY）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
BED BATH & BEYOND, INC.的季度营收约是Orthofix Medical Inc.的1.1倍（$247.8M vs $219.9M），Orthofix Medical Inc.净利率更高（-1.0% vs -6.6%，领先5.6%），BED BATH & BEYOND, INC.同比增速更快（6.9% vs 2.0%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $-12.8M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs -21.1%）
Bed Bath & Beyond曾是美国大型零售连锁企业，主营家居用品、家具及特色家居商品，总部位于新泽西州尤宁郡，业务覆盖美国与加拿大，曾经一度跻身财富世界500强与福布斯全球2000强榜单。该企业于2023年4月申请破产清算，关闭所有剩余门店，现已转型为线上零售品牌。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
BBBY vs OFIX — 直观对比
营收规模更大
BBBY
是对方的1.1倍
$219.9M
营收增速更快
BBBY
高出4.9%
2.0%
净利率更高
OFIX
高出5.6%
-6.6%
自由现金流更多
OFIX
多$29.6M
$-12.8M
两年增速更快
OFIX
近两年复合增速
-21.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $247.8M | $219.9M |
| 净利润 | $-16.4M | $-2.2M |
| 毛利率 | 23.9% | 71.1% |
| 营业利润率 | — | 0.2% |
| 净利率 | -6.6% | -1.0% |
| 营收同比 | 6.9% | 2.0% |
| 净利润同比 | 58.9% | 92.4% |
| 每股收益（稀释后） | $-0.24 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BBBYOFIX
| Q1 26 | $247.8M | — | ||
| Q4 25 | $273.4M | $219.9M | ||
| Q3 25 | $257.2M | $205.6M | ||
| Q2 25 | $282.3M | $203.1M | ||
| Q1 25 | $231.7M | $193.6M | ||
| Q4 24 | $303.2M | $215.7M | ||
| Q3 24 | $311.4M | $196.6M | ||
| Q2 24 | $398.1M | $198.6M |
净利润BBBYOFIX
| Q1 26 | $-16.4M | — | ||
| Q4 25 | $-20.9M | $-2.2M | ||
| Q3 25 | $-4.5M | $-22.8M | ||
| Q2 25 | $-19.3M | $-14.1M | ||
| Q1 25 | $-39.9M | $-53.1M | ||
| Q4 24 | $-81.3M | $-29.1M | ||
| Q3 24 | $-61.0M | $-27.4M | ||
| Q2 24 | $-42.6M | $-33.4M |
毛利率BBBYOFIX
| Q1 26 | 23.9% | — | ||
| Q4 25 | 24.6% | 71.1% | ||
| Q3 25 | 25.3% | 72.2% | ||
| Q2 25 | 23.7% | 68.7% | ||
| Q1 25 | 25.1% | 62.8% | ||
| Q4 24 | 23.0% | 69.0% | ||
| Q3 24 | 21.2% | 68.7% | ||
| Q2 24 | 20.1% | 67.8% |
营业利润率BBBYOFIX
| Q1 26 | — | — | ||
| Q4 25 | -4.8% | 0.2% | ||
| Q3 25 | -4.8% | -8.3% | ||
| Q2 25 | -4.4% | -7.9% | ||
| Q1 25 | -10.0% | -25.2% | ||
| Q4 24 | -11.3% | -5.3% | ||
| Q3 24 | -14.5% | -9.6% | ||
| Q2 24 | -11.8% | -12.5% |
净利率BBBYOFIX
| Q1 26 | -6.6% | — | ||
| Q4 25 | -7.6% | -1.0% | ||
| Q3 25 | -1.8% | -11.1% | ||
| Q2 25 | -6.8% | -6.9% | ||
| Q1 25 | -17.2% | -27.4% | ||
| Q4 24 | -26.8% | -13.5% | ||
| Q3 24 | -19.6% | -13.9% | ||
| Q2 24 | -10.7% | -16.8% |
每股收益（稀释后）BBBYOFIX
| Q1 26 | $-0.24 | — | ||
| Q4 25 | $-0.26 | $-0.05 | ||
| Q3 25 | $-0.07 | $-0.57 | ||
| Q2 25 | $-0.34 | $-0.36 | ||
| Q1 25 | $-0.74 | $-1.35 | ||
| Q4 24 | $-1.68 | $-0.76 | ||
| Q3 24 | $-1.33 | $-0.71 | ||
| Q2 24 | $-0.93 | $-0.88 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $135.8M | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $202.5M | $450.0M |
| 总资产 | $404.5M | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BBBYOFIX
| Q1 26 | $135.8M | — | ||
| Q4 25 | $175.3M | $82.0M | ||
| Q3 25 | $167.4M | $62.9M | ||
| Q2 25 | $120.6M | $65.6M | ||
| Q1 25 | $114.6M | $58.0M | ||
| Q4 24 | $159.2M | $83.2M | ||
| Q3 24 | $140.4M | $30.1M | ||
| Q2 24 | $186.2M | $26.4M |
总债务BBBYOFIX
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | — | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M |
股东权益BBBYOFIX
| Q1 26 | $202.5M | — | ||
| Q4 25 | $217.6M | $450.0M | ||
| Q3 25 | $202.6M | $442.5M | ||
| Q2 25 | $130.9M | $458.3M | ||
| Q1 25 | $143.4M | $458.3M | ||
| Q4 24 | $162.7M | $503.1M | ||
| Q3 24 | $196.2M | $525.9M | ||
| Q2 24 | $250.4M | $546.0M |
总资产BBBYOFIX
| Q1 26 | $404.5M | — | ||
| Q4 25 | $425.5M | $850.6M | ||
| Q3 25 | $414.4M | $832.6M | ||
| Q2 25 | $358.1M | $837.2M | ||
| Q1 25 | $363.7M | $823.1M | ||
| Q4 24 | $402.0M | $893.3M | ||
| Q3 24 | $428.3M | $867.9M | ||
| Q2 24 | $496.8M | $882.0M |
负债/权益比BBBYOFIX
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-11.8M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $-12.8M | $16.8M |
| 自由现金流率自由现金流/营收 | -5.2% | 7.6% |
| 资本支出强度资本支出/营收 | — | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-24.8M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流BBBYOFIX
| Q1 26 | $-11.8M | — | ||
| Q4 25 | $-6.5M | $27.7M | ||
| Q3 25 | $-15.1M | $12.4M | ||
| Q2 25 | $15.8M | $11.6M | ||
| Q1 25 | $-50.9M | $-18.4M | ||
| Q4 24 | $-21.7M | $23.7M | ||
| Q3 24 | $-42.1M | $11.7M | ||
| Q2 24 | $-75.9M | $9.0M |
自由现金流BBBYOFIX
| Q1 26 | $-12.8M | — | ||
| Q4 25 | $-8.6M | $16.8M | ||
| Q3 25 | $-17.4M | $2.5M | ||
| Q2 25 | $14.0M | $4.5M | ||
| Q1 25 | $-52.1M | $-25.1M | ||
| Q4 24 | $-24.7M | $15.2M | ||
| Q3 24 | $-45.5M | $6.3M | ||
| Q2 24 | $-80.4M | $-360.0K |
自由现金流率BBBYOFIX
| Q1 26 | -5.2% | — | ||
| Q4 25 | -3.2% | 7.6% | ||
| Q3 25 | -6.8% | 1.2% | ||
| Q2 25 | 5.0% | 2.2% | ||
| Q1 25 | -22.5% | -13.0% | ||
| Q4 24 | -8.1% | 7.0% | ||
| Q3 24 | -14.6% | 3.2% | ||
| Q2 24 | -20.2% | -0.2% |
资本支出强度BBBYOFIX
| Q1 26 | — | — | ||
| Q4 25 | 0.8% | 4.9% | ||
| Q3 25 | 0.9% | 4.8% | ||
| Q2 25 | 0.6% | 3.5% | ||
| Q1 25 | 0.5% | 3.5% | ||
| Q4 24 | 1.0% | 4.0% | ||
| Q3 24 | 1.1% | 2.7% | ||
| Q2 24 | 1.1% | 4.7% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BBBY
暂无分部数据
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
